$1.45
+0.04 (+2.84%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,777.2% upside
Low Target
$16.99
Average Target
$27.22
High Target
$37.92
Current Price
$1.45
Current
$1.45
$1.45
Target
$27.22
$27.22
$16.99
$27.22 avg
$37.92
Scenario Analysis
Bear Case
$16.99
1,071.7%
Low target
Base Case
$27.22
+1,777.2%
Avg target
Bull Case
$37.92
+2,515.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.45
-67.4% from high
52-Week Low
$1.22
+18.9% from low
Target vs 52W High
$27.22
+512.0% vs high
Next Earnings Report
Nov 18, 2026
4d
until earnings
EPS Est: $-0.34
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |